Lindsey v. Bio-Medical Applications

9 F.4th 317
CourtCourt of Appeals for the Fifth Circuit
DecidedAugust 16, 2021
Docket20-30289
StatusPublished
Cited by10 cases

This text of 9 F.4th 317 (Lindsey v. Bio-Medical Applications) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Lindsey v. Bio-Medical Applications, 9 F.4th 317 (5th Cir. 2021).

Opinion

Case: 20-30289 Document: 00515979904 Page: 1 Date Filed: 08/16/2021

United States Court of Appeals for the Fifth Circuit United States Court of Appeals Fifth Circuit

FILED August 16, 2021 No. 20-30289 Lyle W. Cayce Clerk

Leisha Lindsey,

Plaintiff—Appellant,

versus

Bio-Medical Applications of Louisiana, L.L.C., incorrectly named as Fresenius Medical Care Louisiana Dialysis Group L.L.C.,

Defendant—Appellee.

Appeal from the United States District Court for the Western District of Louisiana USDC No. 1:18-CV-680

Before Ho, Oldham, and Wilson, Circuit Judges. James C. Ho, Circuit Judge:* The Family and Medical Leave Act (“FMLA”) not only entitles eligible workers to take unpaid, job-protected leave for certain specified family and medical reasons. 29 U.S.C. § 2615(a)(1). It also protects workers

* Judge Oldham concurs in the judgment only. Case: 20-30289 Document: 00515979904 Page: 2 Date Filed: 08/16/2021

No. 20-30289

from discriminatory retaliation from their employers in the event they choose to take FMLA leave. Id. § 2615(a)(2). Leisha Lindsey presented prima facie evidence that, after 17 years of dutiful service, her employer, Bio-Medical Applications of Louisiana (“BMA”), terminated her because she was compelled to take FMLA leave in response to a series of personal tragedies. BMA claims she was fired for poor attendance. But employment records suggest BMA offered attendance issues as a post hoc rationalization to justify her firing. BMA also claims she was fired due to a series of missed deadlines. But summary judgment evidence suggests these were hortatory rather than mandatory deadlines, and that she was never informed that failure to meet these deadlines could result in discipline of any kind, let alone termination. We therefore hold that the district court erred in granting summary judgment to BMA on her FMLA discriminatory retaliation claim. But we agree that her remaining claims do not survive summary judgment. Accordingly, we affirm in part and reverse in part and remand for further proceedings. I. Leisha Lindsey began working for BMA in January 1999 as a staff registered nurse and rose through the ranks over the next 17 years. She earned two promotions within four years, rising to the position of Director of Nursing at BMA’s clinic in Bunkie, Louisiana. She became Clinic Manager in 2008, a position she held until BMA terminated her in August 2017. By all accounts, Lindsey was a stand-out employee for nearly her entire tenure. Her supervisor, David Powe, described her as a “really good clinic manager.” She received either a “meets standards” or a “commendable” rating on each of her performance evaluations through 2015.

2 Case: 20-30289 Document: 00515979904 Page: 3 Date Filed: 08/16/2021

But things changed after a series of personal tragedies forced her to take FMLA leave in 2016. Lindsey experienced a fire in her home on July 5. She took one week of leave as a result. Then her son was hospitalized, prompting her to extend her leave for another month. BMA approved Lindsey’s leave under the FMLA through August 15. Even so, she voluntarily continued to perform some of her job responsibilities while on leave, and she told her team that she would “still be available to all of you by text or phone if anyone needs anything.” She also communicated at irregular intervals with Powe and other colleagues via email and text about various work-related issues. On August 31, two weeks after Lindsey returned to work, she attended a meeting with Powe and a coworker named Cecelia Robinson. During that meeting, Robinson suggested that BMA could “distribut[e] medication that came in for deceased patients to other patients.” Lindsey objected, stating that “we’re not going to do that here,” and later followed up with an email to Powe on September 2 explaining why she believed Robinson’s proposal was both illegal and unethical. Powe read the email that morning. Later that same day, Powe prepared a “Corrective Action Form,” claiming that he had received reports from other employees that Lindsey “wasn’t at work” before she took leave several months earlier. He issued the disciplinary form to her the following week. This was the first disciplinary action that Lindsey had ever received in her 17 years of service with BMA. The form stated that Lindsey “ha[d] not been consistently present . . . at the facility during normal hours,” and that this was “affecting the moral [sic] and operations of the facility.” It did not list specific dates or times of her purported absences, however, and Powe was unable to recall them later.

3 Case: 20-30289 Document: 00515979904 Page: 4 Date Filed: 08/16/2021

Powe reevaluated Lindsey’s attendance a few weeks later and determined that she was improving. Nevertheless, he issued a second Corrective Action Form on January 30, 2017, that upgraded BMA’s disciplinary action to a “Final Written Warning.” Powe explained that he issued the form because Lindsey’s attendance “was going back to where it was.” Unlike the first disciplinary form, however, this warning cited three specific incidents of Lindsey’s absenteeism. The first occurred on September 28, 2016, when Powe was unable to reach Lindsey by text message because “she had come in at 10:20 AM” and “had left her phone on her desk” while she was “in the front.” The second occurred on January 11, 2017, when Lindsey advised her secretary that she would be out sick but neglected to inform Powe directly. The third occurred on January 16, 2017, when some BMA employees texted Powe that they had been unable to locate Lindsey that morning. Lindsey objected to both disciplinary forms and refused to sign them. Lindsey repeated her objections in a February 1 email to Powe and a February 6 email to Powe’s supervisor, Carol Dark. Lindsey’s email to Dark complained that she “believed she was being written up as part of her returning from leave of absence.” Dark discussed the email with Powe, but it is unclear whether she reported Lindsey’s complaint to HR. Lindsey claimed that Dark never investigated the complaint and remained “clueless as to facts as they truly are.” Lindsey then began clocking in and out of work to “prov[e] to [Powe and everyone] else” that she was attending work. Powe asked her to stop because Lindsey was an exempt employee and “[e]xempt people don’t clock in and out.” On March 21, 2017, Lindsey received a performance evaluation signed by Powe and Dark with an overall rating of “needs improvement.” She had never received a rating that low in her then-18 years with BMA. The evaluation noted that Lindsey “had some issues of not meeting management

4 Case: 20-30289 Document: 00515979904 Page: 5 Date Filed: 08/16/2021

expectations of being present at the facility during normal operating hours.” But it also noted that Lindsey “made improvements in 2017” and that “[s]taff morale ha[d] also improved.” Also in early 2017, a government contractor named Network 13 consulted with BMA about participating in a “catheter tracking” project. Lindsey was asked to help with the project and to submit a monthly tracking report to Lynda Ball, Network 13’s Quality Improvement Director, by the fifth day of each month. Lindsey understood the fifth to be merely a suggested date and regularly submitted her report after the fifth of each month. Ball sent Lindsey email reminders asking for the monthly report on March 8, May 8, June 5, and July 7, 2017. Ball sent a follow-up email on July 12, copying Dianne Garrand, BMA’s Vice President of Quality. Garrand and Powe attempted to reach Lindsey on July 13 but were unsuccessful. Lindsey later attributed this to her attendance at a manager training meeting, a contention that Powe disputed.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Priest v. Walmart Stores East, LP
S.D. Mississippi, 2025
Harris County v. Hasan Gokal
Court of Appeals of Texas, 2024
Cary v. Sandoz Inc
N.D. Texas, 2024
Jones v. McDonough
S.D. Mississippi, 2022
Burbridge v. CitiMortgage
37 F.4th 1049 (Fifth Circuit, 2022)
Attala County, MS Branch v. Evans
37 F.4th 1038 (Fifth Circuit, 2022)

Cite This Page — Counsel Stack

Bluebook (online)
9 F.4th 317, Counsel Stack Legal Research, https://law.counselstack.com/opinion/lindsey-v-bio-medical-applications-ca5-2021.